skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines defibrotideQuestion & answer

defibrotide · Medicine question

Does it increase bleeding risk?

iatroX medicinesPublished 19 August 2026Reviewed 19 August 2026

The answer

Answer

Yes. Bleeding and low blood pressure are important safety concerns, so staff monitor throughout treatment.

Sources for this answer

Defitelio 80 mg/mL concentrate for solution for infusionemc · SmPC Current selected SmPC · Version 14

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

defibrotide

Read the wider context, including uses, precautions and the sources behind this medicine guide.

Read the defibrotide guide

More questions about defibrotide

What is defibrotide used for?Is it used to prevent veno-occlusive disease?How is it given?Can it be taken at home?Can children receive it?Does it contain an animal-derived ingredient?

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX